Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Digoxin Antikörper

DIG ELISA Wirt: Maus Monoclonal unconjugated
Produktnummer ABIN7212160
  • Target Alle Digoxin (DIG) Produkte
    Digoxin (DIG)
    Reaktivität
    Bitte anfragen
    Wirt
    • 38
    • 18
    • 2
    • 1
    • 1
    Maus
    Klonalität
    • 39
    • 21
    Monoklonal
    Konjugat
    • 22
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser Digoxin Antikörper ist unkonjugiert
    Applikation
    • 26
    • 22
    • 9
    • 6
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA
    Verwendungszweck
    Digoxin Monoclonal Antibody
    Aufreinigung
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
    Immunogen
    Digoxin
    Isotyp
    IgG1
  • Applikationshinweise
    Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: ELISA (1:10000). Not yet tested in other applications.
    Kommentare

    Primary Antibody

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 mg/mL
    Buffer
    PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
  • Target
    Digoxin (DIG)
    Andere Bezeichnung
    Digoxin (DIG Produkte)
    Substanzklasse
    Chemical
    Hintergrund
    Mouse Anti-Digoxin Monoclonal Antibody,Digoxin,The most common indications for digoxin are atrial fibrillation and atrial flutter with rapid ventricular response, though beta blockers and/or calcium channel blockers are a better first choice. There is tentative evidence that digoxin may increase the risk of death, though another meta-analysis reports no change in mortality. High ventricular rate leads to insufficient diastolic filling time. By slowing down the conduction in the AV node and increasing its refractory period, digoxin can reduce the ventricular rate. The arrhythmia itself is not affected, but the pumping function of the heart improves, owing to improved filling.,Digoxin
Sie sind hier:
Kundenservice